Netoglitazone
Chemical compound
- None
- 5-[(6-[(2-Fluorophenyl)methoxy]naphthalen-2-yl)methyl]-1,3-thiazolidine-2,4-dione
- 161600-01-7 Y
- 204109
- 2707
- DB09199
- 176806 N
- QOV2JZ647A
- D05150 Y
- DTXSID5043712
- Interactive image
- C1=CC=C(C(=C1)COC2=CC3=C(C=C2)C=C(C=C3)CC4C(=O)NC(=O)S4)F
InChI
- InChI=1S/C21H16FNO3S/c22-18-4-2-1-3-16(18)12-26-17-8-7-14-9-13(5-6-15(14)11-17)10-19-20(24)23-21(25)27-19/h1-9,11,19H,10,12H2,(H,23,24,25) N
- Key:PKWDZWYVIHVNKS-UHFFFAOYSA-N N
Netoglitazone (also called MCC-555) is a hypoglycemic agent belonging to the thiazolidinedione group.[1]
References
- ^ Lazarenko OP, Rzonca SO, Suva LJ, Lecka-Czernik B (January 2006). "Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat". Bone. 38 (1): 74–84. doi:10.1016/j.bone.2005.07.008. PMC 1850100. PMID 16137931.
- v
- t
- e
Oral diabetes medication, insulins and insulin analogs, and other drugs used in diabetes (A10)
|
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e